Paragon Biosciences Evozyne Holdings, LLC

Biotechnology company · Chicago, Illinois, United States

Paragon Biosciences Evozyne Holdings, LLC is a biotechnology company headquartered in Chicago, Illinois, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $9 million sold in a notice filed in 2020.

Profile compiled from public records. Is this your company? Request a correction or update

Paragon Biosciences Evozyne Holdings at a glance

Typebiotechnology company
HeadquartersChicago, Illinois, United States
Earliest incorporation on record2019
SEC CIK1811338

What does Paragon Biosciences Evozyne Holdings do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $9 million sold (2020).

Frequently asked questions about Paragon Biosciences Evozyne Holdings

Where is Paragon Biosciences Evozyne Holdings headquartered?

Paragon Biosciences Evozyne Holdings, LLC is headquartered in Chicago, Illinois, United States.

What does Paragon Biosciences Evozyne Holdings do?

Paragon Biosciences Evozyne Holdings, LLC is a biotechnology company.

When was Paragon Biosciences Evozyne Holdings founded?

The earliest incorporation on record for Paragon Biosciences Evozyne Holdings, LLC is in 2019, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences